EU approves AbbVie's Skyrizi for children with plaque psoriasis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. ORCL
2. NVDA
3. SPY
4. USO
5. SRRK
6. DFTX
7. AZN
8. CGEM
9. SATL
10. LYNX

Go back to EU approves AbbVie's Skyrizi for children with plaque psoriasis
AbbVie (NYSE: ABBV) Delayed: 262.38 +5.26 (2.05%)
Previous Close $257.12    52 Week High $68.12 
Open $261.67    52 Week Low $50.71 
Day High $264.65    P/E 56.92 
Day Low $260.10    EPS $4.61 
Volume 1,240,630